Aguilar; Angelo
Patent Applications and Registrations
Patent applications and USPTO patent grants for Aguilar; Angelo.The latest application filed is for "small molecule menin inhibitors".
- Aguilar; Angelo - Ann Arbor MI
| Patent | Date |
|---|---|
| MDM2 protein degraders Grant 11,192,898 - Wang , et al. December 7, 2 | 2021-12-07 |
| Small Molecule Menin Inhibitors App 20210353610 - WANG; Shaomeng ; et al. | 2021-11-18 |
| Small Molecule Mdm2 Protein Degraders App 20210309666 - Wang; Shaomeng ; et al. | 2021-10-07 |
| Piperidines As Menin Inhibitors App 20210198237 - Wang; Shaomeng ; et al. | 2021-07-01 |
| Small molecule MDM2 protein degraders Grant 11,046,703 - Wang , et al. June 29, 2 | 2021-06-29 |
| Piperidines as covalent menin inhibitors Grant 11,045,448 - Wang , et al. June 29, 2 | 2021-06-29 |
| Piperidine Compounds As Covalent Menin Inhibitors App 20210115018 - WANG; Shaomeng ; et al. | 2021-04-22 |
| Piperidines as menin inhibitors Grant 10,899,738 - Wang , et al. January 26, 2 | 2021-01-26 |
| Monofunctional Intermediates For Ligand-dependent Target Protein Degradation App 20210002289 - Li; Yangbing ; et al. | 2021-01-07 |
| Monofunctional intermediates for ligand-dependent target protein degradation Grant 10,759,808 - Wang , et al. Sep | 2020-09-01 |
| Small Molecule Mdm2 Protein Degraders App 20200109149 - Wang; Shaomeng ; et al. | 2020-04-09 |
| Piperidines As Covalent Menin Inhibitors App 20200022953 - Wang; Shaomeng ; et al. | 2020-01-23 |
| 9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors Grant 10,307,407 - Wang , et al. | 2019-06-04 |
| Piperidines As Menin Inhibitors App 20190152947 - Wang; Shaomeng ; et al. | 2019-05-23 |
| Mdm2 Protein Degraders App 20190127387 - Wang; Shaomeng ; et al. | 2019-05-02 |
| Monofunctional Intermediates For Ligand-dependent Target Protein Degradation App 20190119289 - Wang; Shaomeng ; et al. | 2019-04-25 |
| 9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors Grant 10,253,044 - Wang , et al. | 2019-04-09 |
| 9h-pyrimido [4,5-b] Indoles As Bet Bromodomain Inhibitors App 20180036294 - WANG; Shaomeng ; et al. | 2018-02-08 |
| MDM2 inhibitors and therapeutic methods using the same Grant 9,745,314 - Wang , et al. August 29, 2 | 2017-08-29 |
| 9h-pyrimido [4,5-b]indoles And Related Analogs As Bet Bromodomain Inhibitors App 20170210761 - Wang; Shaomeng ; et al. | 2017-07-27 |
| 9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors Grant 9,580,430 - Wang , et al. February 28, 2 | 2017-02-28 |
| Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same Grant 9,403,856 - Wang , et al. August 2, 2 | 2016-08-02 |
| Bcl-2/bcl-xl Inhibitors And Therapeutic Methods Using The Same App 20150336994 - Wang; Shaomeng ; et al. | 2015-11-26 |
| Mdm2 Inhibitors And Therapeutic Methods Using The Same App 20150299211 - Wang; Shaomeng ; et al. | 2015-10-22 |
| 9h-pyrimido[4,5-b]indoles And Related Analogs As Bet Bromodomain Inhibitors App 20150246923 - Wang; Shaomeng ; et al. | 2015-09-03 |
| BCL-2/BCL-XL inhibitors and therapeutic methods using the same Grant 9,096,625 - Wang , et al. August 4, 2 | 2015-08-04 |
| Bcl-2/bcl-xl Inhibitors And Therapeutic Methods Using The Same App 20140199234 - Wang; Shaomeng ; et al. | 2014-07-17 |
| Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same Grant 8,691,184 - Wang , et al. April 8, 2 | 2014-04-08 |
| Spiro-oxindole MDM2 antagonists Grant 8,629,141 - Wang , et al. January 14, 2 | 2014-01-14 |
| Spiro-oxindole Mdm2 Antagonists App 20120289494 - Wang; Shaomeng ; et al. | 2012-11-15 |
| Bcl-2/bcl-xl Inhibitors And Therapeutic Methods Using The Same App 20120189539 - Wang; Shaomeng ; et al. | 2012-07-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 